SecFilingDex

Abivax S.A. (ABVX, AAVXF)

22 SEC EDGAR filings indexed (CIK 0001956827) across 7 form types.

Filing profile

Abivax S.A. (ABVX, AAVXF) has 22 SEC filings indexed on SecFilingDex, across 7 form types filed over roughly 3 years, from October 23, 2023 to July 2, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the 6-K (Foreign event) with 8 filings — Material disclosure filed by foreign private issuers as required by their home country. 13 of these filings were disclosed in the twelve months to July 2, 2026. 2 of the 22 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 86-KForeign event · event-driven
  • 4424B5Prospectus supplement · event-driven
  • 320-FForeign annual · annual
  • 3SC 13G5%+ passive stake · event-driven
  • 2SC 13G/A5%+ passive stake · event-driven
  • 1SC 13D5%+ activist stake · event-driven (within 10 days)
  • 1424B4Final prospectus · event-driven

Profile derived from 22 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1956827&type=&dateb=&owner=include&count=40 ↗

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.